ONWARD Medical N.V., a medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury, provided a Q1 2024 business update.

Theradaptive, Inc., a regenerative medicine company developing targeted therapeutics, announced it has been awarded funding from the Maryland Stem Cell Research Fund to support human clinical trials for its lead product, OsteoAdapt SP.

DENTSPLY SIRONA Inc. announced that its Board of Directors declared a quarterly cash dividend of $0.16 per share of common stock, an indicated annual rate of $0.64 per share.

Orchestra BioMed Holdings, Inc. announced that company management will present and be available for one-on-one meetings at the Jefferies Global Healthcare Conference being held in New York, NY, June 4-6, 2024.

Covalon Technologies Ltd., an advanced medical technologies company, will release its Q2 Fiscal 2024 financial results on Wednesday, May 29, 2024, before markets open.

SeaStar Medical Holding Corporation announces the publication of a manuscript citing four case studies in which critically ill patients between the ages of 22 months and 71 years with multiorgan failure who were treated with the Selective Cytopheretic Device successfully stabilized and improved their clinical status prior to stem cell or liver transplant,...